Abacus Life, Inc. (ABL)
(Delayed Data from NSDQ)
$8.56 USD
-0.07 (-0.81%)
Updated Nov 5, 2024 04:00 PM ET
After-Market: $8.57 +0.01 (0.12%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$8.56 USD
-0.07 (-0.81%)
Updated Nov 5, 2024 04:00 PM ET
After-Market: $8.57 +0.01 (0.12%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Zacks News
Are Options Traders Betting on a Big Move in Abacus Life (ABL) Stock?
by Zacks Equity Research
Investors need to pay close attention to Abacus Life (ABL) stock based on the movements in the options market lately.
Sun Life (SLF) Q3 Earnings Top Estimates
by Zacks Equity Research
Sun Life (SLF) delivered earnings and revenue surprises of 3.20% and 5.19%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Abacus Life, Inc. (ABL) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Abacus Life, Inc. (ABL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Do Options Traders Know Something About Abacus Life (ABL) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Abacus Life (ABL) stock based on the movements in the options market lately.
Nasdaq Expands Presence in Latin America With New Agreement
by Zacks Equity Research
Nasdaq extends agreement with Nubank to provide AxiomSL regulatory reporting solution to the later and expands presence in Latin America.
What Makes Abacus Life, Inc. (ABL) a Strong Momentum Stock: Buy Now?
by Zacks Equity Research
Does Abacus Life, Inc. (ABL) have what it takes to be a top stock pick for momentum investors? Let's find out.
Buy 4 Low-Beta Stocks & Forget About Volatility: ERIE, SFM, AVO, ABL
by Nilanjan Banerjee
It is imperative to build a portfolio of low-beta stocks to sail through a volatile market. ERIE, SFM, AVO & ABL are well-poised to gain.
Strength Seen in Abacus Life, Inc. (ABL): Can Its 5.4% Jump Turn into More Strength?
by Zacks Equity Research
Abacus Life, Inc. (ABL) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Does Abacus Life, Inc. (ABL) Have the Potential to Rally 34.62% as Wall Street Analysts Expect?
by Zacks Equity Research
The mean of analysts' price targets for Abacus Life, Inc. (ABL) points to a 34.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Do Options Traders Know Something About Abacus Life (ABL) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Abacus Life (ABL) stock based on the movements in the options market lately.
Cboe Global Rallies 17% YTD: Can the Stock Retain the Bull Run?
by Zacks Equity Research
CBOE's strong market position, global reach, proprietary products strength and solid capital position poise it well for growth.
Can Abacus Life, Inc. (ABL) Run Higher on Rising Earnings Estimates?
by Zacks Equity Research
Abacus Life, Inc. (ABL) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Wall Street Analysts Predict a 32.72% Upside in Abacus Life, Inc. (ABL): Here's What You Should Know
by Zacks Equity Research
The consensus price target hints at a 32.7% upside potential for Abacus Life, Inc. (ABL). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
GoHealth (GOCO) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
GoHealth (GOCO) delivered earnings and revenue surprises of 69.64% and 23.83%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
FinWise Bancorp (FINW) Tops Q2 Earnings Estimates
by Zacks Equity Research
FinWise Bancorp (FINW) delivered earnings and revenue surprises of 41.18% and 0.19%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Abacus Life, Inc. (ABL) Stock Jumps 20.3%: Will It Continue to Soar?
by Zacks Equity Research
Abacus Life, Inc. (ABL) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.